Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial

Stopped Standard clinical practice at site caused unforeseen issues for the use of the ACM

Conditions

• Anemia
• End Stage Renal Disease

Interventions

• DEVICE: Anemia Control Model (ACM)
• DRUG: IV iron
• DRUG: Erythropoiesis-Stimulating Agent (ESA)

Sponsor

Vifor Fresenius Medical Care Renal Pharma

Collaborators

• [object Object]
• [object Object]